Safety and Efficacy Study of Topical Bromfenac Versus Placebo to Treat Ocular Inflammation After Cataract Surgery
Status:
Completed
Trial end date:
2004-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to investigate the efficacy of bromfenac sodium
ophthalmic solution 0.09% for treatment of post-operative ocular inflammation in subjects who
undergo cataract extraction and intraocular lens implantation. The secondary objective was to
investigate the safety and tolerability of the same.